A study prevalence ocular comorbidity among diabetes patients as per the glycemic control at tertiary health care center

 

Manish Pendse¹, Priyadarshini Cholera^2*

 

 REFERENCES

1. International Diabetes Federation: Diabetes Atlas. 2nd edition. Brussels: Gan D, Ed. Belgium; 2003.
2. Thomas JS: Disability in Diabetes[A]. National Diabetes Data Group. Diabetes in America[M]. Bethesda 2nd edition. 1995. NIH Publication NO.9521468
3. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H: The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005, 28(9):2130-2135.
4. Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(1):4-14.
5. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21(9):1414-1431.
6. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362(12):1090-1101.
7. Lee ET, Keen H, Bennett PH, Fuller JH, Lu M: Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia 2001, 44(Suppl 2(2)):S3-13.
8. LeRoith D, Fonseca V, Vinik A: Metabolic memory in diabetes--focus on insulin. Diabetes Metab Res Rev 2005, 21(2):85-90.
9. Turner RC, Holman RR: Lessons from UK prospective diabetes study. Diabetes Res Clin Pract 1995, 28(Suppl(7)):S151-157
10. Priya PV, SrinivasaRao A, Sharma JVC. DR can lead to complete blindness. 2013. Available from: https://www.researchgate.net/publication/282609747_Diabetic_Retinopathy_-_Can_Lead_to_Complete_Blindness.
11. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al.. Retinopathy in Diabetes. Diabetes Care. 2004;27(1):s84-s87.
12. Goh PP, Ismail M, Hussein E. Status of DR among diabetics registered to the Diabetic Eye Registry, National Eye Database, 2007. Med J Malaysia. 2008;63(Suppl C):24-28.
13. Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with DR in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3(1):1-4.
14. Bin-Bin H, Li W, Yun-Juan G, Jun-Feng H, Ming L, Yu-Xiang L, et al.. Factors associated with diabetic retinopathy in chinese patients with Type 2 Diabetes Mellitus. Int J Endocr. 2012;2012:157940.
15. Kahlon AS, Pathak R. Patterns of glycemic control using glycosylated hemoglobin in diabetics. J Pharm Bioall Sci. 2011;3(3):324-328.
16. Zhang X, Zhao J, Zhao T, Liu H. Effects of intensive glycemic control in ocular complications in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. Endocrine. 2015;49(1):78-79.
17. Hasniza Zaman Huri , Chua Chew Huey , Norasyikin Mustafa et al.. Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia. Braz. J. Pharm. Sci. 2018;54(2):e17484.